Background In rituximab-treated patients with rheumatoid arthritis, humoral and cellular immune
responses after two or three doses of SARS-CoV-2 vaccines are not well characterised. …

The SARS-CoV-2 Omicron variant has more than 15 mutations in the receptor binding domain
of the Spike protein enabling increased transmissibility and viral escape from antibodies …

Methods| Patients from 3 university hospitals who were enrolled beginning on March 23,
2021, in an ongoing observational cohort study on immune responses after 2 doses of mRNA …

Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is
largely unknown. Understanding the development of protective immunity is of paramount …

Diagnostic assays currently used to monitor the efficacy of COVID-19 vaccines measure levels
of antibodies to the receptor-binding domain of ancestral SARS-CoV-2 (RBDwt). However…

Following three doses of the SARS-CoV-2 vaccines 30%–40% of kidney transplant (KTx)
recipients remain without relevant antibody response. 1 Here, we report the effect of a fourth …

B‐cell depletion induced by anti‐cluster of differentiation 20 (CD20) monoclonal antibody (mAb)
therapy of patients with lymphoma is expected to impair humoral responses to severe …

Objectives Humoral vaccine responses to SARS-CoV-2 vaccines are impaired and short
lasting in patients with immune-mediated inflammatory diseases (IMID) following two vaccine …

Poor overall survival of hematopoietic stem cell transplantation (HSCT) recipients who
developed COVID-19 underlies the importance of SARS-CoV-2 vaccination. Previous studies of …

Background The durability of vaccine-induced humoral immunity against SARS-CoV-2 in
patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy …